Investing.com - KORU Medical Systems (NASDAQ: KRMD) reported third quarter EPS of $-0.010, $0.03 better than the analyst estimate of $-0.040. Revenue for the quarter came in at $8.2M versus the consensus estimate of $7.68M.
Guidance
KORU Medical Systems sees Q4 2024 revenue of $32.750M-$33.250M versus the analyst consensus of $32.170M.
KORU Medical Systems's stock price closed at $3.20. It is up 38.530% in the last 3 months and up 39.130% in the last 12 months.
KORU Medical Systems saw 2 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See KORU Medical Systems's stock price’s past reactions to earnings here.
According to InvestingPro, KORU Medical Systems's Financial Health score is "good performance".
Check out KORU Medical Systems's recent earnings performance, and KORU Medical Systems's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar